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Acute retinal necrosis syndrome (ARNS) is a herpetic infectious eye disease that presents clinicians 
with diﬃcult decisions to make about the indication and timing of surgical intervention.  Here I report 
2 patients who underwent prophylactic and early vitrectomy with good visual outcomes.  Case 1,  a 
72-year-old man,  had a second recurrence of ARNS in the left eye in 2011 and underwent early vitrec-
tomy in the acute inﬂammatory phase to remove previously formed vitreous opacity and vitreoretinal 
adhesions,  in parallel with intravenous acyclovir and oral prednisolone administration.  He had expe-
rienced ARNS in the right eye in 1983,  in the left eye in 1986,  and a recurrence in the left eye in 1999.  
Case 2,  a 66-year-old woman,  developed ARNS in the right eye.  All of the circumferential retinal 
lesions became degenerative with intravenous acyclovir and prednisolone.  She underwent a vitrectomy 
in the post-inﬂammatory phase,  since epiretinal proliferation was noted through vitreous opacity with 
complete posterior vitreous detachment.  These cases suggest that early vitrectomy in the acute inﬂam-
matory phase would be indicated for pre-existing vitreoretinal adhesions,  while prophylactic vitrec-
tomy in the post-inﬂammatory phase would be indicated for epiretinal proliferation.
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cute retinal necrosis syndrome is a clinically 
deﬁned entity of herpetic retinitis,  occurring in 
otherwise systemically healthy patients.  The extent of 
retinal involvement with herpetic necrotic lesions dif-
fers from patient to patient: in some patients,  entire 
circumferential lesions rapidly become conﬂuent and 
extend to the posterior pole with sheathing of all reti-
nal arteries,  and these lesions are designated as the 
fulminant type; in other patients,  self-limiting necrotic 
lesions scatter in the fundus,  and these are designated 
the mild type [1,  2].  Vitreous opacity and subsequent 
formation of vitreoretinal adhesions,  caused by vitre-
ous inﬂammation in association with herpetic retinitis,  
are major factors leading to rhegmatogenous and trac-
tion retinal detachment in the late post-inﬂammatory 
phase of the disease.
　 Vitrectomy,  entire circumferential scleral buck-
ling (encircling),  and silicone oil tamponade,  which are 
often combined with cataract surgery,  are mandatory 
to achieve retinal reattachment for rhegmatogenous 
and traction retinal detachment with multiple retinal 
tears after the fulminant type of acute retinal necrosis 
syndrome [3].  Early vitrectomy is deﬁned as vitrec-
tomy in the acute inﬂammatory phase,  whereas pro-
phylactic vitrectomy is deﬁned as vitrectomy in the 
post-inﬂammatory phase to prevent the supposed 
development of retinal detachment.  These 2 phrases 
are often used interchangeably.  Several case reports 
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[4-7] and case series [8,  9] have described success-
ful early and prophylactic vitrectomy in acute retinal 
necrosis syndrome to prevent retinal detachment.  
However,  the indication and the timing for early and 
prophylactic vitrectomy in acute retinal necrosis syn-
drome remain to be determined.  In this report,  I 
described early vitrectomy for recurrent mild-type 
acute retinal necrosis syndrome in the acute inﬂamma-
tory phase and prophylactic vitrectomy for ﬁrst-pre-
senting fulminant-type acute retinal necrosis syndrome 
in the post-inﬂammatory phase,  and discussed the 
indication and the timing of surgical intervention.  
Patients and Methods
　 Medical records were retrospectively reviewed for 
2 consecutive patients who had undergone prophy-
lactic or early vitrectomy with a transconjunctival 
25-gauge trocar system at Okayama University 
Hospital.  Informed consent for vitrectomy was obtained 
from each patient after the risks and beneﬁts of surgi-
cal intervention were explained.
Case Reports
　 Case 1. A 72-year-old man presented with a 
2-week history of blurred vision in the left eye in 
February 2011.  His best-corrected visual acuity was 
0.5 in the right eye and 0.6 in the left.  The intraocu-
lar pressure was 15mmHg in the right eye and 26 
mmHg in the left.  Each eye had an intraocular lens 
implantation.  The right eye had chorioretinal degen-
eration but no aqueous inﬂammation.  The left eye had 
2＋muttonfat keratic precipitates and several aqueous 
cells.  A large retinal necrotic lesion (Fig.  1D) was 
observed temporal to the macular area through dense 
vitreous opacity (Fig.  1C) in the left eye.
　 He had experienced acute retinal necrosis syn-
drome in the right eye in July 1983 and in the left eye 
in May 1986,  as described in detail in a previous 
report [10].  On those 2 occasions,  he was given 
intravenous prednisolone alone but no acyclovir.  In 
March 1999,  acute retinal necrosis syndrome recurred 
in the left eye,  and he underwent a 2-week course of 
intravenous acyclovir 1,500mg daily,  combined with 
oral prednisolone tapered from 20mg daily.  The 
superonasal midperipheral necrotic lesions became 
inactive chorioretinal scars,  together with the initial 
chorioretinal scars mainly located on the temporal 
side,  as described in a previous report [11].  He 
underwent cataract surgery in both eyes in 2004.  In 
December 2006,  he underwent vitrectomy in the right 
eye for traction retinal detachment caused by dense 
vitreous opacity and vitreoretinal adhesions with cho-
rioretinal scars (Fig.  1A).  Mild vitreous opacity was 
left behind in the left eye (Fig.  1B).  His visual acuity 
in November 2010 was 0.7 in the right eye and 0.8 in 
the left.
　 In 1962,  this patient had experienced right upper 
lung lobectomy for pulmonary tuberculosis and blood 
transfusion.  In December 2003,  transfusion hepati-
tis-screening programs detected that he was positive 
for hepatitis C virus (HCV) antibody with HCV-RNA 
400IU/mL and genotype 1b.  Observation was chosen 
because there was neither a rise in serum liver 
enzymes nor abnormalities on ultrasonographic liver 
examinations.  However,  when his serum liver enzyme 
levels rose in October 2008,  he was treated with 
peginterferon-α2a and ribavirin from then until 
November 2009,  successfully eradicating the HCV.
　 In February 2011,  he underwent vitrectomy in the 
left eye to remove vitreous opacity and to release old 
vitreoretinal adhesions,  together with endo-laser 
photocoagulation applied to the previously degenera-
tive retina and around the new lesions (Fig.  1E).  At 
the same time,  he received a 9-day course of acyclo-
vir 1,500mg daily,  combined with oral prednisolone 
tapered from 20mg daily,  which was followed by a 
2-week course of oral valacyclovir 3,000mg daily.  
The necrotic lesions and laser spots became degenera-
tive (Fig.  1F).  His visual acuity was 0.5 in the right 
eye and 1.0 in the left.  The aqueous inﬂammation 
subsided,  and the intraocular pressure returned to a 
normal level in the left eye,  with 0.1ｵ betametha-
sone,  latanoprost,  and dorzolamide-timolol eye drops.
　 Case 2. In March 2011,  a 66-year-old woman 
developed acute retinal necrosis syndrome in the right 
eye,  involving the entire retinal quadrants with total 
arterial and venous sheathing,  together with dense 
vitreous opacity (Fig.  2A).  Her best-corrected visual 
acuity was 0.05 in the right eye and 1.2 in the left.  
Intraocular pressure was 28mmHg in the right eye and 
17mmHg in the left.  Her right eye had 2＋muttonfat 
keratic precipitates but no aqueous cells.  She was 
taking toremifene citrate 40mg daily after a right-side 
breast cancer resection combined with sentinel lymph 
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node dissection in 2009.  
　 She was given 0.1ｵ betamethasone and timolol eye 
drops in the right eye,  and treated with a 2-week 
course of intravenous acyclovir 1,500mg daily,  com-
bined with intravenous prednisolone tapered from 100 
mg daily,  followed by oral valacyclovir 3,000mg daily 
for 2 weeks in combination with oral prednisolone 
tapering.  The retinal necrotic lesions became degen-
erative,  but her visual acuity in the right eye was 
0.08,  due mainly to the vitreous opacity.  She was 
observed after developing complete posterior vitreous 
detachment with no vitreoretinal adhesion in the right 
eye (Fig.  2C).  In June 2011,  epiretinal proliferation 
with tangential retinal traction was noted in the super-
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Fig.  1　 Case 1.  Fundus photographs (A,  B) in July 2010,  showing retinal degeneration (arrow in A) on the temporal side with periph-
eral residual vitreoretinal adhesion after vitrectomy in the right eye (A) and moderate vitreous opacity in the left eye (arrowhead in B) as 
sequelae to the 2 preceding episodes of acute retinal necrosis syndrome.  Slit-lamp biomicroscopic photograph (C) and fundus photograph 
(D) in the left eye in February 2011 showing diﬀuse vitreous opacity (arrow in C) and new retinal necrotic lesions (arrow in D) temporal to 
the macula,  with aggregated dense vitreous opacity superior to the optic disc (arrowhead in D).  Merged fundus photographs (E) in the left 
eye,  2 days after vitrectomy,  showing retinal necrotic lesions (arrow in E) with scattered laser photocoagulation to the atrophic retina and 
around the new lesions.  Fundus photograph (F) in the left eye,  16 days after vitrectomy,  showing that the retinal necrotic lesions and laser 
spots have become degenerative (arrows in F).
otemporal midperipheral retina to the posterior pole 
(Fig.  2D).  Vitrectomy,  endo-laser panretinal photo-
coagulation,  and air tamponade,  combined with cata-
ract surgery,  were performed to remove epiretinal 
proliferation,  together with vitreous opacity (Fig.  
2B).  Her visual acuity in the right eye became 0.5.
Discussion
　 Acute retinal necrosis syndrome in the ﬁrst patient 
(Case 1) was a re-recurrence and classiﬁed as the mild 
type.  The vitreous opacity was a combination of 
sequelae to 2 episodes of previous inﬂammation and the 
immediate consequence of the present inﬂammation.  
The vitreous opacity prevented the new retinal 
necrotic lesions from being visualized clearly.  
Vitreoretinal adhesions,  as sequelae to the previous 
inﬂammation,  would be suspected to induce traction 
retinal detachment under the new inﬂammation.  
Vitrectomy was thus performed during the acute 
inﬂammatory phase and was called an early vitrec-
tomy.
　 In contrast,  acute retinal necrosis syndrome in the 
second patient (Case 2) was the fulminant type,  
involving the entire retina.  Complete posterior vitre-
ous detachment developed spontaneously in the acute 
inﬂammatory phase; thus,  an early vitrectomy was not 
planned.  The development of epiretinal proliferation 
with tangential retinal traction was noted in the post-
inﬂammatory phase,  and vitrectomy was done at this 
time as a prophylactic vitrectomy against subsequent 
retinal detachment.
　 Laser photocoagulation was also advocated as a 
prophylactic against retinal detachment in acute reti-
nal necrosis syndrome [12,  13].  Based on this rec-
ommendation,  laser photocoagulation was applied to 
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Fig.  2　 Case 2.  Merged fundus photographs (A) in the right eye taken on March 11,  2011,  showing retinal necrotic lesions covering the 
entire retina with dense vitreous opacity.  Fundus photographs in the right eye taken on April 27 (C) and June 8 (D),  showing retinal 
degeneration with no proliferation under dense vitreous opacity (C),  and epiretinal proliferation extending from the superotemporal midpe-
riphery to the posterior pole (arrows in D),  respectively.  Merged fundus photographs (B) taken on June 29 after vitrectomy showing removal 
of epiretinal proliferation (arrows in B).
the ﬁrst patient (Case 1) during vitrectomy around 
active retinal necrotic lesions and also on the atrophic 
retina as sequelae to the previous retinal inﬂamma-
tion.  Panretinal photocoagulation was performed 
during vitrectomy in the second patient (Case 2) to 
cover the entire atrophic retina in the post-inﬂamma-
tory phase.
　 The ﬁrst patient (Case 1) develop acute retinal 
necrosis syndrome three times in the same (left) eye.  
The patient happened to have hepatitis C virus 
infection and underwent virus eradication therapy.  
Immunomodulation,  caused possibly by HCV itself and 
also by interferon therapy,  might underlie the 
repeated activation of herpetic viruses in the same 
eye.
　 The formation of vitreoretinal adhesions,  followed 
by vitreous traction caused by inﬂammation-induced 
vitreous gel contraction in the post-inﬂammatory 
phase,  leads to traction and rhegmatogenous retinal 
detachment with multiple retinal tears in acute retinal 
necrosis syndrome [1-3].  Spontaneous formation of 
complete posterior vitreous detachment in the acute 
inﬂammatory phase or in the late post-inﬂammatory 
phase is a good sign of the absence of vitreoretinal 
adhesions [1,  2].  Even under the circumstances 
described in Case 2,  epiretinal proliferation would 
develop in the background of persistent weak inﬂam-
mation and would cause tangential retinal traction,  
leading ﬁnally to traction and rhegmatogenous retinal 
detachment.  Prophylactic vitrectomy to remove 
epiretinal proliferation under complete posterior vit-
reous detachment in the post-inﬂammatory phase has 
the rationale of preventing the subsequent development 
of traction and rhegmatogenous retinal detachment.  In 
addition,  pre-existing vitreous opacity with apparent 
vitreoretinal adhesions would be better removed by 
early vitrectomy even in the acute inﬂammatory phase 
to visualize the fundus and to avoid traction and rheg-
matogenous retinal detachment under active inﬂamma-
tion,  as shown in Case 1.
　 In conclusion,  the timing of surgical intervention is 
crucial to good visual outcome in prophylactic and 
early vitrectomy for acute retinal necrosis syndrome.  
In the post-inﬂammatory phase,  one indication for 
surgical intervention would be to remove epiretinal 
proliferation,  which causes tangential retinal traction 
even in the absence of vitreoretinal adhesions,  spe-
ciﬁcally under complete posterior vitreous detach-
ment.  Another indication would be to release apparent 
and marked vitreoretinal adhesions even in the acute 
inﬂammatory phase as well as in the late post-inﬂam-
matory phase of the disease.
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